Crossmark Global Holdings’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $1.21M | Buy |
|
|||||
|
2025
Q3 | $1.2M | Sell |
|
|||||
|
2025
Q2 | $1.73M | Buy |
|
|||||
|
2025
Q1 | $1.27M | Sell |
|
|||||
|
2024
Q4 | $1.46M | Sell |
|
|||||
|
2024
Q3 | $1.26M | Buy |
|
|||||
|
2024
Q2 | $2.11M | Buy |
|
|||||
|
2024
Q1 | $2.56M | Sell |
|
|||||
|
2023
Q4 | $2.35M | Sell |
|
|||||
|
2023
Q3 | $1.74M | Sell |
|
|||||
|
2023
Q2 | $2.73M | Buy |
|
|||||
|
2023
Q1 | $2.38M | Sell |
|
|||||
|
2022
Q4 | $2.4M | Buy |
|
|||||
|
2022
Q3 | $1.7M | Sell |
|
|||||
|
2022
Q2 | $1.6M | Buy |
|
|||||
|
2022
Q1 | $2.73M | Buy |
|
|||||
|
2021
Q4 | $2.82M | Sell |
|
|||||
|
2021
Q3 | $5.16M | Sell |
|
|||||
|
2021
Q2 | $4.36M | Sell |
|
|||||
|
2021
Q1 | $3.91M | Sell |
|
|||||
|
2020
Q4 | $4.45M | Buy |
|
|||||
|
2020
Q3 | $3.65M | Buy |
|
|||||
|
2020
Q2 | $3.51M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $264K | Buy |
|